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Background
Severe exfoliative diseases of the skin (Erythema multi-
forme, Stevens–Johnson syndrome - SJS, toxic epidermal
necrolysis -TEN) are a result of an immunological
reaction to foreign antigens, most frequently caused by
drug consumption. It is characterized by extensive
damage to the skin and mucous membranes due to
detachment at the dermoepidermal junction, very similar
to post-combustional lesions.
This article wants to emphasize on the role of the plastic
surgeon in the management of exfoliative diseases of the
skin and the reason why patients suffering from SJS or
TEN should be directed and treated in burn intensive care
units, where they can receive adequate fluid resuscitation,
nutritional support, wound care and physical therapy.
Methods
We have carried out a retrospective study between Septem-
ber 2012 and April 2013 on all patients with SJS or TEN
treated in our Burn ICU based on medical records, clinical
examination, local examination, dynamic evaluation of vital
parameters (blood, wound secretion, vital functions).
Results
All patients presented local or systemic complications
that were treated adequately. Excepting one patient who
died due to sepsis, all other patients survived.
Conclusion
Treatment of severe exfoliative skin diseases is a complex
process that requires a multidisciplinary approach, but the
most important decision is to direct the patient to a burn
intensive care unit.
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